ロード中...
Chimeric Antigen Receptor T cells for Multiple Myeloma: The Journey So Far – And the Road Ahead
Despite improvements in effective therapy, multiple myeloma remains incurable and virtually all patients will face relapsed disease at some point after diagnosis. The prognosis for relapsed myeloma after developing resistance to anti-CD38 monoclonal antibodies, proteasome inhibitors, immunomodulator...
保存先:
| 出版年: | Cancer J |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7988823/ https://ncbi.nlm.nih.gov/pubmed/33750070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000506 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|